and etoposide , 250 mg/m2 daily for 3 days followed by autologous bone marrow transplant ( abmt ) has been successfully used to treat 62 patients with hodgkin 's disease recurrent or refractory after mechlorethamine , vincristine , procarbazine , prednisone , doxorubicin , bleomycin , vinblastine , dacarbazine ( mopp/abvd ) -like regimens .
C0042670
vinblastine
C0280554
mopp/abvd